The consumer shift toward plant-based nutrition has extended well beyond food into the supplement category. Botanical extracts, algae-derived ingredients, and whole-plant concentrates are reshaping what wellness products look like — and raising important questions about efficacy, standardisation, and regulatory compliance.
The Appeal of Plant-Based Ingredients
Consumer motivation for plant-based supplements is multifactorial: perceived naturalness, environmental concerns, cultural and religious dietary requirements, and a growing distrust of synthetic actives all contribute. For brands, botanical ingredients offer differentiation in a crowded market, storytelling potential, and — when well-chosen — genuine scientific backing.
The most commercially significant plant-based supplement categories include turmeric (curcumin), green tea extract (EGCG), berberine, saffron, ginger, and a growing portfolio of Ayurvedic and Traditional Chinese Medicine herbs now entering mainstream Western markets. Each comes with its own evidence base, bioavailability challenges, and regulatory considerations.
Bioavailability: The Central Challenge
Many plant polyphenols are poorly absorbed from the gut due to low aqueous solubility, rapid metabolism, and extensive first-pass elimination. Curcumin, for example, has notoriously low bioavailability in its standard form — a challenge addressed through various delivery technologies including phospholipid complexation (Meriva®), nanoparticle encapsulation, and piperine co-administration. Without such enhancement, even high-dose curcumin supplements may deliver negligible systemic exposure.
Formulators must therefore distinguish between raw botanical extract content and biologically available active compound. Labelling a product by weight of herb rather than standardised active content can mislead consumers and regulators alike, and is increasingly scrutinised by market surveillance authorities across the EU.
Standardisation and Quality Control
Botanical raw material quality varies considerably depending on species, origin, harvest season, storage, and extraction method. Reputable suppliers provide certificates of analysis confirming active compound content, microbial safety, heavy metal levels, and absence of pesticide residues. ISO 17025-accredited laboratory testing is essential in the due diligence process for botanical ingredient sourcing.
Standardised extracts — where the active marker compound is guaranteed at a minimum threshold — are preferable both for reproducibility of effect and for regulatory substantiation of claims. A consistent and well-characterised extract is a prerequisite for clinical trials and, subsequently, for authorised health claims under EU law.
Regulatory Positioning
The EU Traditional Herbal Medicinal Products Directive (2004/24/EC) provides a registration route for well-established botanical medicines, but most botanical supplements are regulated as food supplements under Directive 2002/46/EC. Novel Food Regulation (EU) 2015/2283 applies to ingredients without a history of significant food use in the EU before May 1997 — a designation that catches many emerging botanicals and requires pre-market authorisation.
